drugset / Trial / NCT06376396

Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

NCT06376396

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to compare the combination albendazole and praziquantel versus albendazole alone in patients affected by neurocysticercosis.

Timeline

Start
2024-06
Primary completion
2025-12
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule Oral
Subject Praziquantel Small molecule Oral

Indications